Qin Wenjing, Xiao Chengcheng, Yang Jing, Hu Mei, Chang Liying, Zhu Yanhan
Department of Neurology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Department of Rehabilitation Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Front Neurol. 2025 Aug 20;16:1630773. doi: 10.3389/fneur.2025.1630773. eCollection 2025.
The clinical utility of the National Institutes of Health Stroke Scale, Glasgow Coma Scale, and modified Rankin Scale scores in predicting prognosis is well established. However, whether the Acute Physiology and Chronic Health Evaluation System II (APACHE II) score can predict mortality in patients with large vessel occlusion stroke (LVOS) admitted to the neurology intensive care unit (NICU) following endovascular treatment (EVT) remains unclear. This study aims to evaluate the ability of the APACHE II score to predict mortality in post-EVT LVOS patients admitted to the NICU.
This retrospective cohort study enrolled 93 consecutive patients (65 males; mean age, 68.0 years) with acute anterior circulation LVOS who underwent EVT. Patients were categorized into survival and death groups based on their 28-day post-EVT survival status. APACHE II scores of the two groups were compared. Receiver operating characteristic (ROC) curve analysis was employed to assess the sensitivity, specificity, and optimal threshold of APACHE II scores in predicting mortality. Model calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test. Multivariable logistic regression was performed to estimate odds ratios (ORs) for mortality prediction.
Of the 93 enrolled patients, 74 (79.6%) survived and 19 (20.4%) died within 28 days. The death group had significantly higher APACHE II scores than the survival group [(21.84 ± 4.10) points vs. (13.05 ± 5.54) points, < 0.001]. ROC analysis revealed excellent discriminative capacity (AUC 0.912, 95% CI 0.850-0.973), with an optimal threshold of 16.5 points (sensitivity 94.7%, specificity 75.7%). The mortality rate was 1.8% for patients with APACHE II scores <16.5 points and 50.0% for those with APACHE II scores ≥16.5 points. The model demonstrated good calibration ( = 0.878). Further, multivariable analysis confirmed both APACHE II scores (OR = 1.239, 95% CI 1.029-1.491, = 0. 023) and cerebral hernia (OR = 11.404, 95% CI 1.507-86.314, = 0. 018) as independent predictors.
APACHE II score assessed within 24 h post-EVT provides robust prediction of 28-day mortality in acute anterior circulation LVOS patients admitted to the NICU.
美国国立卫生研究院卒中量表、格拉斯哥昏迷量表和改良Rankin量表评分在预测预后方面的临床效用已得到充分证实。然而,急性生理与慢性健康状况评估系统II(APACHE II)评分能否预测接受血管内治疗(EVT)后入住神经重症监护病房(NICU)的大血管闭塞性卒中(LVOS)患者的死亡率仍不清楚。本研究旨在评估APACHE II评分预测入住NICU的EVT后LVOS患者死亡率的能力。
这项回顾性队列研究纳入了93例连续接受EVT治疗的急性前循环LVOS患者(65例男性;平均年龄68.0岁)。根据患者EVT后28天的生存状态分为生存组和死亡组。比较两组的APACHE II评分。采用受试者操作特征(ROC)曲线分析评估APACHE II评分预测死亡率的敏感性、特异性和最佳阈值。使用Hosmer-Lemeshow拟合优度检验评估模型校准。进行多变量逻辑回归以估计死亡率预测的比值比(OR)。
在93例纳入的患者中,74例(79.6%)存活,19例(20.4%)在28天内死亡。死亡组的APACHE II评分显著高于生存组[(21.84±4.10)分对(13.05±5.54)分,P<0.001]。ROC分析显示具有良好的区分能力(AUC 0.912,95%CI 0.850-0.973),最佳阈值为16.5分(敏感性94.7%,特异性75.7%)。APACHE II评分<16.5分的患者死亡率为1.8%,评分≥16.5分的患者死亡率为50.0%。该模型显示出良好的校准(P=0.878)。此外,多变量分析证实APACHE II评分(OR=1.239,95%CI 1.029-1.491,P=0.023)和脑疝(OR=11.404,95%CI 1.507-86.314,P=0.018)均为独立预测因素。
EVT后24小时内评估的APACHE II评分可为入住NICU的急性前循环LVOS患者28天死亡率提供可靠预测。